| Identification |
| Name: | 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one,11-[2-[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro- |
| Synonyms: | 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one,11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro- (9CI); AF-DX116; Otenzepad |
| CAS: | 102394-31-0 |
| Molecular Formula: | C24H31 N5 O2 |
| Molecular Weight: | 421.53524 |
| InChI: | InChI=1S/C24H31N5O2/c1-3-27(4-2)16-18-10-7-8-15-28(18)17-22(30)29-21-13-6-5-11-19(21)24(31)26-20-12-9-14-25-23(20)29/h5-6,9,11-14,18H,3-4,7-8,10,15-17H2,1-2H3,(H,26,31) |
| Molecular Structure: |
![(C24H31N5O2) 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one,11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-di...](https://img1.guidechem.com/chem/e/dict/20/102394-31-0.jpg) |
| Properties |
| Density: | 1.171 g/cm3 |
| Water Solubility: | Soluble to 25 mM in DMSO |
| Solubility: | Soluble to 25 mM in DMSO |
| Biological Activity: | Selective M 2 muscarinic receptor antagonist. K i values are 64, 417, 786, 211 and 5130 nM for human recombinant M 2 , M 1 , M 3 , M 4 and M 5 muscarinic receptors, respectively. |
| Safety Data |
| |
 |
